Tesamorelin - 10mg

Tesamorelin is a synthetic peptide analog of growth hormone–releasing hormone (GHRH), engineered to stimulate the pituitary gland’s natural production and pulsatile release of growth hormone (GH). It features a stabilized amino acid sequence that resists enzymatic degradation, enhancing its potency and half-life compared to endogenous GHRH. Tesamorelin has been extensively studied for its effects on body composition, lipid metabolism, and cellular repair. While it is FDA-approved for specific clinical use in HIV-associated lipodystrophy, it is also widely researched in broader contexts of metabolic health, body recomposition, and longevity science.

What Are the Effects of Tesamorelin?

• Growth Hormone & IGF-1 Stimulation: Tesamorelin binds to GHRH receptors in the anterior pituitary, promoting natural GH release and downstream IGF-1 elevation—supporting tissue growth, recovery, and cellular repair.
• Reduction in Visceral Fat: Clinical and preclinical research consistently demonstrates Tesamorelin’s ability to reduce deep abdominal (visceral) adipose tissue, improving metabolic profile and insulin sensitivity.
• Lean Muscle Preservation: Studies show Tesamorelin helps preserve lean body mass while promoting lipolysis, contributing to improved body composition and physical performance in research models.
• Cognitive & Neuroprotective Effects: Emerging data suggest Tesamorelin may enhance cognitive function and protect neuronal health by improving cerebral lipid metabolism and reducing neuroinflammation.
• Improved Sleep & Recovery: By supporting optimal GH rhythms, Tesamorelin has been linked to enhanced sleep quality, faster tissue recovery, and greater energy restoration following physical exertion.
• Metabolic & Cardiovascular Support: Research indicates Tesamorelin may help lower triglyceride levels, improve lipid oxidation, and support vascular health via GH-mediated metabolic regulation.
• Safety Observations: Clinical studies report Tesamorelin is generally well tolerated, with mild injection-site irritation and transient gastrointestinal discomfort being the most common effects. No evidence suggests carcinogenicity or systemic toxicity in controlled environments.